Matthew Flitter

1.8k total citations · 1 hit paper
9 papers, 889 citations indexed

About

Matthew Flitter is a scholar working on Psychiatry and Mental health, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matthew Flitter has authored 9 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Physiology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matthew Flitter's work include Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (5 papers) and Medical Imaging Techniques and Applications (4 papers). Matthew Flitter is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (5 papers) and Medical Imaging Techniques and Applications (4 papers). Matthew Flitter collaborates with scholars based in United States, Italy and France. Matthew Flitter's co-authors include Mark A. Mintun, Abhinay D. Joshi, Michael J. Pontecorvo, P. Murali Doraiswamy, Ming‐Chi Lu, Carl Sadowsky, Adam Fleisher, Daniel Skovronsky, Anupa Arora and Christopher M. Clark and has published in prestigious journals such as The Lancet Neurology, Neurobiology of Aging and Journal of Nuclear Medicine.

In The Last Decade

Matthew Flitter

8 papers receiving 880 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

2012 572 citations Christopher M. Clark, Michael J. Pontecorvo et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Flitter United States	5	632	621	231	224	103	9	889
Virginia Pappas United States	4	549 0.9×	444 0.7×	167 0.7×	148 0.7×	85 0.8×	8	764
Clare L. Smith Australia	9	658 1.0×	713 1.1×	263 1.1×	246 1.1×	144 1.4×	25	1.2k
J. Koivunen Finland	7	601 1.0×	579 0.9×	146 0.6×	230 1.0×	70 0.7×	8	779
VL Villemagne Australia	3	576 0.9×	629 1.0×	331 1.4×	251 1.1×	152 1.5×	8	1.0k
Chris C. Rowe Australia	11	473 0.7×	576 0.9×	235 1.0×	233 1.0×	108 1.0×	17	965
Eric Triau Belgium	5	386 0.6×	465 0.7×	189 0.8×	174 0.8×	89 0.9×	10	738
Kerstin Heurling Sweden	18	354 0.6×	530 0.9×	230 1.0×	141 0.6×	198 1.9×	43	1.0k
Karly Alex Cody United States	14	484 0.8×	417 0.7×	160 0.7×	137 0.6×	71 0.7×	42	827
Lyduine E. Collij Netherlands	17	432 0.7×	394 0.6×	275 1.2×	192 0.9×	72 0.7×	51	767
Denise A. Reyes United States	12	670 1.1×	800 1.3×	470 2.0×	372 1.7×	186 1.8×	19	1.3k

Countries citing papers authored by Matthew Flitter

Since Specialization

Citations

This map shows the geographic impact of Matthew Flitter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Flitter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Flitter more than expected).

Fields of papers citing papers by Matthew Flitter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Flitter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Flitter. The network helps show where Matthew Flitter may publish in the future.

Co-authorship network of co-authors of Matthew Flitter

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Flitter. A scholar is included among the top collaborators of Matthew Flitter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Flitter. Matthew Flitter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Southekal, Sudeepti, Michael D. Devous, Michael Navitsky, et al.. (2019). DT‐01‐05: TEMPORAL LOBE QUANTITATION OF FLORTAUCIPIR PET IMAGES MAY IMPROVE DETECTION OF INTERMEDIATE NEUROFIBRILLARY TANGLE PATHOLOGY IN AUTOPSY‐VALIDATED CASES. Alzheimer s & Dementia. 15(7S_Part_28).

Arora, Anupa, Michael J. Pontecorvo, Mark A. Mintun, et al.. (2019). Evaluation of a visual read method for flortaucipir PET Scans. 60. 252–252. 1 indexed citations

Pontecorvo, Michael J., Andrew Siderowf, Bruno Dubois, et al.. (2017). Effectiveness of Florbetapir PET Imaging in Changing Patient Management. Dementia and Geriatric Cognitive Disorders. 44(3-4). 129–143. 32 indexed citations

Shcherbinin, Sergey, Adam J. Schwarz, Abhinay D. Joshi, et al.. (2016). Kinetics of the Tau PET Tracer ¹⁸F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease. Journal of Nuclear Medicine. 57(10). 1535–1542. 80 indexed citations

Pontecorvo, Michael J., Michael Grundman, Bruno Dubois, et al.. (2015). DT‐02‐03: A randomized, controlled, multicenter, international study of the impact of florbetapir (¹⁸F) PET amyloid imaging on patient management and outcome. Alzheimer s & Dementia. 11(7S_Part_7). 2 indexed citations

Grundman, Michael, Michael J. Pontecorvo, Stephen Salloway, et al.. (2012). Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline. Alzheimer Disease & Associated Disorders. 27(1). 4–15. 93 indexed citations

Sperling, Reisa A., Keith A. Johnson, P. Murali Doraiswamy, et al.. (2012). Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiology of Aging. 34(3). 822–831. 105 indexed citations

Clark, Christopher M., Michael J. Pontecorvo, Thomas G. Beach, et al.. (2012). Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. The Lancet Neurology. 11(8). 669–678. 572 indexed citations breakdown →

Sperling, Reisa A., Keith A. Johnson, Michael J. Pontecorvo, et al.. (2009). P1‐084: PET imaging of β‐amyloid with florpiramine F18 (18F‐AV‐45): Preliminary results from a phase II study of cognitively normal elderly subjects, individuals with mild cognitive impairment, and patients with a clinical diagnosis of Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_7). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact